Open AccessPotent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Author(s) -
Michael S. Piepenbrink,
Jun-Gyu Park,
Ashlesha Deshpande,
Andreas Loos,
Chengjin Ye,
Madhubanti Basu,
Sanghita Sarkar,
Ahmed Magdy Khalil,
David Chauvin,
Jennifer Woo,
Philip Lovalenti,
Nathaniel Erdmann,
Paul A. Goepfert,
Vu Truong,
Richard A. Bowen,
Mark R. Walter,
Luis Martínez-Sobrido,
James J. Kobie
Publication year - 2022
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1010691
Subject(s) - monoclonal antibody , virology , coronavirus , antibody , respiratory system , middle east respiratory syndrome coronavirus , biology , neutralizing antibody , in vivo , coronaviridae , immunology , virus , medicine , covid-19 , genetics , disease , infectious disease (medical specialty)